Proteon Therapeutics' Kidney Disease Drug Flunks Phase III Trial - BioSpace

Proteon Therapeutics' Kidney Disease Drug Flunks Phase III Trial  BioSpace

Proteon Therapeutics, based in Waltham, Mass., announced that its PATENCY-2 Phase III clinical trial of vonapanitase in chronic kidney disease (CKD) failed to ...